8.00-8.30 Symposia 1: AstraZeneca
Covid-19 and transplant patients
(John Søfteland, Sahlgrenska University Hospital)
8.30-9.00 Symposia 2: GSK
Practicalities of setting up and running a Covid medicines delivery unit and administering sotrovimab
(Cecilia Priestley & Sarah Williams, Dorset County Hospital NHS Foundation Trust)
9.00-9.30 Symposia 3: Pfizer
Neandertal gene variants and COVID-19
(Hugo Zeberg, Karolinska Institutet)
Lars-Magnus Andersson, Sahlgrenska University Hospital/Östra
Anders Johansson, University Hospital of Umeå, Umeå University
Martin Sundqvist, Örebro University Hospital, Örebro University
Moderator: Jan Albert, Karolinska Institutet & Magnus Lindh, Sahlgrenska University Hospital
The evolution of SARS-CoV-2. Where are we heading?
(Emma Hodcroft, University of Bern)
Viral kinetics during SARS-CoV-2 infection
(Christopher Chiu, Imperial College London)
Less is more? Ct-values for quantitation beyond Covid-19
(Emmi Andersson, Public Health Agency of Sweden)
Discussion
Moderator: Marcus Buggert, Karolinska Institutet & Anna Smed Sörensen, Karolinska Institutet
Antibody responses to SARS-CoV-2 infection and vaccination
(Florian Krammer, Icahn School of Medicine at Mount Sinai)
Longitudinal responses to mRNA vaccination at Elderly Care Homes in Sweden
(Mattias Forsell, Umeå University)
Vaccination in older adults
(Dorota Religa, Karolinska Institutet)
Discussion
Moderator: Anders Johansson, Umeå University Hospital, Umeå University
Who is most at risk of dying from COVID-19? Using UK patient records to investigate in a pandemic
(Helen McDonald, London School of Hygiene and Tropical Medicine)
Excess mortality during pandemics – not so easy to measure as it may seem
(Jonas Björk, Lund University)
Prospects for real-time surveillance at the human-animal interface
(Fernanda Dórea, National Veterinary Institute)
Discussion
Moderator: Martin Sundqvist, Örebro University Hospital, Örebro University
O1: Impaired diffusion capacity after COVID-19 is not associated with self-perceived breathlessness or non-physiological responses to exertion
(Johan Normark, Umeå University)
O2: SARS-CoV-2 vaccination boosts neutralising antibodies in the upper respiratory tract in previously infected individuals
(Julia Svensson, Karolinska Institutet)
O3: Monocyte infiltration, dendritic cell depletion in blood and airways and functional deficits in blood associate with COVID-19 severity but normalize
(Björn Österberg, Karolinska Institutet)
O4: Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination among healthcare workers
(Isabell Wagenhäuser, University Hospital Wuerzburg)
O5: Occupational variation in the risk of Covid-19 infection and hospitalization among foreign-born healthcare workers in Sweden: a registry-based study
(Chioma Nwaru, University of Gothenburg)
O6: One-year mortality and hospital-free days in COVID-19 versus non-COVID-19 critical illness
(Pontus Hedberg, Karolinska Institutet et al.)